--- title: "Controlled medication abroad: what Japan, the UAE, and South Korea confiscate from your suitcase" excerpt: "Japan bans pseudoephedrine, found in cold medicines like Actifed and Vicks inhaler, and treats amphetamines such as Venvanse and, in certain cases, Ritalin as banned substances in checked baggage. The United Arab Emirates bars codeine and any product containing cannabidiol, even with a valid medical prescription. South Korea requires prior authorization through the Narcotics Information Portal for controlled medication covering more than thirty days of treatment. In all three cases, the problem is rarely the medication itself: it's the absence of a Japanese Yakkan Shoumei, an English-language prescription, or the correct form. Checking the bottle in the large suitcase, undeclared, is the costliest mistake at the border." description: "Japan bans pseudoephedrine, found in cold medicines like Actifed and Vicks inhaler, and treats amphetamines such as Venvanse and, in certain cases, Ritalin as banned substances in checked baggage. The United Arab Emirates bars codeine and any product containing cannabidiol, even with a valid medical prescription. South Korea requires prior authorization through the Narcotics Information Portal for controlled medication covering more than thirty days of treatment. In all three cases, the problem is rarely the medication itself: it's the absence of a Japanese Yakkan Shoumei, an English-language prescription, or the correct form. Checking the bottle in the large suitcase, undeclared, is the costliest mistake at the border." slug: "remedio-controlado-exterior-receita-paises-proibem-2026" locale: "en" canonical: "https://voyspark.com/en/journal/remedio-controlado-exterior-receita-paises-proibem-2026" author: "Curadoria Voyspark" published_at: "Wed Sep 09 2026 02:27:42 GMT+0000 (Coordinated Universal Time)" updated_at: "Wed Sep 09 2026 04:43:32 GMT+0000 (Coordinated Universal Time)" vertical: "hacking" reading_time_minutes: 19 word_count: 4309 hero_image: "https://s3.voyspark.com/voyspark-images/articles/remedio-controlado-exterior-receita-paises-proibem-2026/hero-4eb184.jpg" tags: - "medication-abroad" - "controlled-substances" - "japan-yakkan-shoumei" - "travel-health" - "prescription-travel" - "customs-rules" --- # Controlled medication abroad: what Japan, the UAE, and South Korea confiscate from your suitcase ### 1. Why medicine-cabinet drugs become a police matter in three popular countries **TL;DR**: Medication sold over the counter in Brazil can be a controlled drug under a different legal system. Japan, the United Arab Emirates, and South Korea classify substances by psychoactive effect, not by the label on the box. The result: a traveler with Venvanse, codeine, or CBD in their toiletry bag becomes a customs case before they even leave the airport. Every drug-control system starts from the same logic: classify the substance by its effect on the central nervous system, not by the commercial name printed on the box. Amphetamine is amphetamine, whether inside Venvanse, inside Vyvanse, or in powder bought on the street. Codeine is an opioid, whether in a pediatric cough syrup or in a pill of dubious origin. It's this pharmacological logic, not the traveler's intent, that decides whether the suitcase sails through the belt or turns into a recorded incident. Brazil regulates much of this class as prescription-only medication: controlled sale, but legal at any pharmacy with a prescription. Japan, the United Arab Emirates, and South Korea treat the same molecule as a narcotic or stimulant subject to local drug law, a category normally used to crack down on trafficking. There's no comfortable middle ground: either the traveler fits the documented exception (Yakkan Shoumei, prior approval, HSA license) or the substance is treated like any drug seized in an ordinary bust, with no distinction between patient and trafficker. The issue isn't exclusive to these three countries: Singapore, Saudi Arabia, and mainland China have similar lists. The difference is that Japan, the UAE, and South Korea together account for millions of Brazilian connections and landings every year, which makes the risk statistically relevant rather than a travel-forum curiosity. The practical consequence: anyone traveling with Ritalin, Venvanse, codeine, or CBD needs to treat their toiletry bag as part of the trip's paperwork, not as a last-minute detail sorted out in the check-in line. The sections that follow show what each country requires, the document that resolves most cases, and the mistake that shows up most often in airport-detention accounts: checking the medication without declaring it. --- ### 2. Japan: why Venvanse, Adderall, and Ritalin don't get in the way they sit in your toiletry bag **TL;DR**: Japan's Stimulants Control Law treats amphetamine as a hard drug, with no exception for a foreign prescription. Venvanse and Adderall are barred even with a medical report. Ritalin gets in at personal-use quantities with a Yakkan Shoumei, but faces strict screening because it contains methylphenidate, a controlled psychotropic substance in the country. Japan splits controlled medication into two distinct drawers, and mixing them up is the most common mistake among travelers who research in a hurry. The first drawer is stimulants classified under the Kakuseizai Torishimari Hou (Stimulants Control Law): amphetamine and its derivatives, which includes Venvanse (lisdexamfetamine) and Adderall. For this category, no Yakkan Shoumei will help. Entry is banned even for someone who has taken the medication under prescription for years: the medical report doesn't change the molecule's classification. The second drawer is common psychotropics, where Ritalin (methylphenidate) sits. Here there's a legal path: up to one month of treatment in a quantity matching the prescription can travel in luggage without extra procedure, and larger quantities require a Yakkan Shoumei. Even so, methylphenidate gets extra scrutiny at screening, because Japan restricts its internal therapeutic use to hypersomnia and narcolepsy, not ADHD, which makes customs officers question the reason for treatment more often than they would with a common antidepressant. Pseudoephedrine rounds out the problematic trio. It's the decongestant in formulas like Actifed and in Vicks inhaler, and it's banned above a very low concentration under the same stimulants law, because it's a precursor chemical for methamphetamine. A Brazilian cold medicine with pseudoephedrine in the formula, even bought without a prescription at a neighborhood pharmacy, lands on the automatic-seizure list. | Substance | Common brand name | Status in Japan | |---|---|---| | Lisdexamfetamine | Venvanse, Vyvanse | Banned, no prescription exception | | Amphetamine | Adderall, Dexedrine | Banned, no prescription exception | | Methylphenidate | Ritalin, Concerta | Allowed at personal-use quantities, Yakkan Shoumei above 1 month | | Pseudoephedrine | Actifed, Vicks inhaler | Banned above minimum concentration | | Codeine | Combination syrups and painkillers | Allowed at low dose, Yakkan Shoumei above the limit | --- ### 3. Yakkan Shoumei: the document that clears prescription medication in Japan **TL;DR**: Yakkan Shoumei is the import certificate issued by Japan's regional quarantine stations under the Ministry of Health. It applies to prescribed medication beyond one month of treatment, takes 1 to 2 weeks to process, and must be requested before departure, never on arrival at the airport. Yakkan Shoumei (薬監証明) is the certificate that authorizes personal import of prescription medication above the exemption threshold. The rule of thumb: up to one month of prescribed medication and up to two months of over-the-counter medication or vitamins pass without a certificate, as long as the substance itself isn't banned outright (like amphetamine). Beyond that, or for items like insulin syringes in large quantities, the Yakkan Shoumei becomes mandatory. The request is filed with the regional quarantine stations of the Ministry of Health, Labour and Welfare (Kouseiroudoushou), by mail or fax, with a completed form, a copy of the medical prescription, and generally a letter from the doctor describing the diagnosis and dosage. The process isn't instant: the timeline usually runs one to two weeks, which rules out any chance of sorting it out the day before the flight. Applicants receive the certificate by mail or email and need to bring it printed, along with the medication in its original packaging, to present to inspectors at Narita, Haneda, or Kansai. One detail that catches unprepared travelers off guard: the Yakkan Shoumei authorizes entry of an allowed substance in a larger quantity, but it doesn't turn a banned substance into a permitted one. Requesting a certificate for Venvanse is a wasted request, because the stimulants law doesn't grant exceptions through an import certificate, only through quantity within an already-permitted category. Before starting the process, it's worth confirming which of the two drawers from the previous section the medication falls into. It's worth remembering that the certificate isn't required only for entry: anyone carrying medical supplies like syringes, needles, or an insulin pump in quantities above strict daily use also needs the document, even with no connection to a psychoactive substance. And the Yakkan Shoumei's validity is tied to the trip declared in the application, so it doesn't work as a permanent authorization for future re-entries: every trip with medication above the exempt quota requires a new application, filed again with the same one-to-two-week lead time. --- ### 4. United Arab Emirates: codeine, tramadol, and the CBD that doesn't exist under local law **TL;DR**: The UAE enforces Federal Law No. 14 of 1995 on narcotics with unusual strictness toward tourists. Codeine, tramadol, and benzodiazepines require prior MOHAP approval above personal-use quantities. Cannabidiol is banned at any THC level, including products sold freely in the United States and Europe. Few tourist destinations combine as much international connecting traffic with as much medication strictness as the United Arab Emirates. The legal basis is Federal Law No. 14 of 1995 on narcotics, which doesn't distinguish, in cold print, between a patient with a prescription and someone carrying illicit drugs: it distinguishes only whether the substance is on the controlled list and whether prior authorization exists. Codeine, found in combination painkillers and some syrups, and tramadol, a common opioid for chronic pain, are on the list of items requiring prior approval from the Ministry of Health and Prevention (MOHAP) when the quantity exceeds the equivalent of short-term personal treatment. The request is filed through the MOHAP portal, with a medical prescription, a medical report, and in many cases a copy of the passport, and it's best to start the process at least two to three weeks in advance, because approval isn't automatic. Cannabidiol is the case that surprises Brazilian and American travelers alike: in the UAE there's no legal distinction between CBD with THC and without THC. Full-spectrum, isolate, or broad-spectrum CBD oil bought entirely legally at a US pharmacy is a controlled drug on Emirati soil, with no exception for THC content. The same applies to CBD gummies and capsules, a common item in the toiletry bag of travelers managing anxiety or insomnia. | Substance | Common use | UAE rule | |---|---|---| | Codeine | Painkiller, cough suppressant | Prior MOHAP approval above personal use | | Tramadol | Chronic pain | Prior MOHAP approval, limited quantity | | Cannabidiol (CBD) | Anxiety, insomnia, pain | Banned at any THC level | | Diazepam and benzodiazepines | Anxiety, insomnia | Prior MOHAP approval | | Melatonin | Sleep | Tolerated in small personal quantities | --- ### 5. South Korea: the Narcotics Information Portal and the 30-day rule **TL;DR**: South Korea uses the Ministry of Food and Drug Safety (MFDS) portal to authorize psychotropic or narcotic medication beyond 30 days of treatment. The process takes 7 to 10 business days and requires a prescription, a medical report, and proof of dosage in English or Korean. South Korea's rule mirrors, under a different name, the same Japanese logic: up to 30 days of treatment with common psychotropic medication travels without extra procedure, as long as it's declared if questioned and carried in the original packaging with the prescription. Beyond 30 days, or for any quantity of a substance classified as a narcotic or stimulant (which includes methylphenidate at high doses), the traveler needs prior authorization processed by the Ministry of Food and Drug Safety (MFDS) through the Narcotics Information Portal, the country's official system for controlled-medication imports. The application requires a medical prescription, a doctor's letter explaining the diagnosis and dosage, and generally a copy of the passport and travel itinerary. The timeline stated by the agency itself runs seven to ten business days, which pushes planning to at least two weeks before departure, with margin for a follow-up request if a document is missing. One point that sets Korea apart from Japan: the Korean system is more lenient with low-dose methylphenidate within the 30-day quota, because the country treats ADHD as a recognized therapeutic indication, unlike Japan. This doesn't apply to pure amphetamine like Venvanse or Adderall, which remain in the stricter control category and require the same prior-approval process, with a real risk of denial depending on the application's history. Anyone transiting through Korea on the way to another destination, even without leaving Incheon airport, should carry the documentation: baggage on an international connection goes through X-ray and can be inspected even without leaving the transit area. --- ### 6. Singapore: the HSA and the license nobody reads before boarding **TL;DR**: Singapore's Health Sciences Authority requires prior licensing for controlled medication like Ritalin, Adderall, and certain opioids above the personal-use quota. The request is filed online, with a prescription and passport, and applies even to travelers only connecting through Changi. Singapore enforces one of the strictest anti-drug laws in the world, and the strictness extends to common prescription medication. The Health Sciences Authority (HSA) is the agency that administers the list of controlled drugs and psychotropic substances, and any medication on that list above the personal quota (typically defined relative to one month of treatment) requires an import license requested before travel, through the HSA's own website. The list includes Ritalin and Concerta (methylphenidate), Adderall and Vyvanse (amphetamine and lisdexamfetamine), most benzodiazepines used for anxiety and insomnia, and opioids like codeine at high doses. The license application requires a copy of the passport, a medical prescription, and sometimes a doctor's letter, and the result usually comes back within a few business days when the application is complete, though there's no guarantee of automatic approval for every substance. The detail most people miss: the requirement also applies to those merely connecting through Singapore's Changi Airport, even without leaving the international area. Carry-on baggage gets opened for routine inspection just as often as for those who officially land in the country, and controlled medication without a license found in a backpack during a four-hour layover has already led to documented detention in traveler accounts and embassy alerts. Anyone traveling to Japan or Australia with a layover in Changi should treat the connection as part of the route subject to Singaporean law, not as neutral territory. The Brazil-Asia route often runs through exactly this kind of hub: São Paulo to Tokyo or Seoul with a layover in Singapore, Doha, or Dubai is a common cheaper-itinerary design. That means the typical Brazilian traveler headed to Japan frequently crosses two or three distinct jurisdictions on the same trip, each with its own list of controlled substances, which reinforces why checking every leg of the route matters as much as checking the final destination. --- ### 7. The English-language prescription: the minimum document that solves 80% of cases **TL;DR**: A medical prescription in English, with the substance's generic name, dosage, and treatment duration, is the document that prevents most border problems. On its own it doesn't replace a Yakkan Shoumei or prior approval when local law requires one, but it's usually enough for quantities within the personal-use quota. Before any country-specific procedure, there's a baseline document that makes a difference at practically every border in the world: a medical prescription in English, with the substance's generic name (not just the Brazilian brand name), the daily dosage, and the expected treatment duration. Many Brazilian doctor's offices issue prescriptions with only the brand name, which is already a problem, because Venvanse means nothing to an officer trained to recognize lisdexamfetamine. It's best to ask the doctor for a complementary letter, not just the pharmacy prescription: a paragraph on letterhead explaining the diagnosis, the medication's generic name, dosage, and reason for treatment, with the doctor's registration number and signature. This document, even without a certified translation, is usually enough for quantities within the personal-use quota at almost any destination: the United States, the European Union, the United Kingdom, and most of Latin America require nothing beyond this for common medication. Where this document falls short is exactly in the three countries covered in this report, when the substance is on the stricter list: Venvanse doesn't get into Japan even with a letter signed by a department head, and codeine above the quota doesn't clear the UAE without MOHAP's prior approval, no matter how well-written the English prescription is. The prescription eases everyday friction and is a documentary prerequisite for requesting a Yakkan Shoumei, Korean authorization, or an HSA license, but it doesn't replace the formal procedure when the law requires one. It's also worth keeping the doctor's name and a contact number on the letter itself, because part of the approval process in each of the four systems described in this report asks for the possibility of direct confirmation with the prescriber, something rare in practice but that official forms leave as a mandatory field. --- ### 8. Checking medication in the large suitcase: the costliest mistake **TL;DR**: Controlled medication should travel in carry-on luggage, in its original packaging, with the prescription attached. Checking it in the large suitcase creates two simultaneous risks: loss, which separates the patient from treatment, and loss of traceability, which makes it hard to prove legitimate possession if the suitcase is opened and inspected without the owner present. The mistake that shows up most often in accounts of avoidable detention isn't a missing Yakkan Shoumei or MOHAP approval: it's checking controlled medication inside the large suitcase, alongside clothes and shoes, instead of carrying it in hand luggage. This creates two problems at once, and both work against the traveler. The first is logistical: checked baggage has a much higher rate of loss or delay than carry-on, and an international connection in Doha, Dubai, or Seoul raises that risk further. Anyone dependent on daily medication, like an ADHD stimulant or an anticonvulsant, ends up without their medication at the exact moment they'd need it most, with the suitcase stuck at a hub thousands of kilometers away. The second problem is legal, and more serious: checked luggage gets inspected without the owner present to explain context. If a hold scanner flags a controlled substance inside a suitcase with no passenger there to present a prescription on the spot, what would have been a quick check turns into a formal case, with the suitcase held and the passenger called in for questioning hours later, having already missed their connecting flight. Medication in carry-on luggage, in its original packaging with the name printed on it and the physical prescription on top, solves both problems at once: it reduces the risk of going without treatment and ensures the patient is present for any explanation, document in hand, the moment the question is asked. No airline guarantees a delivery timeline for lost baggage, and reimbursement claims for medication lost in a suitcase usually run into declared-value clauses that most passengers never fill out before check-in. Carrying it in hand luggage eliminates that entire discussion before it even starts. --- ### 9. Practical checklist: what to do two weeks before boarding **TL;DR**: Two weeks of lead time is the realistic minimum to gather an English prescription, request a Yakkan Shoumei, MOHAP approval, or Korean authorization where applicable, and organize carry-on luggage. Leaving it until the last minute is the most common reason medication gets barred for lack of time, not lack of entitlement. Planning for controlled medication headed to Japan, the United Arab Emirates, or South Korea follows a logical order worth laying out as a simple roadmap. First, identify which list the substance falls under in each destination or connecting country, using the tables in sections 2 and 4 as a starting point and confirming through the country's official channel, because the list changes over time. Second, ask the doctor for the English prescription with generic name, dosage, and duration, plus the complementary letter described in section 7. Third, if the country requires a formal procedure (Yakkan Shoumei in Japan, MOHAP approval in the UAE, the Narcotics Information Portal in South Korea, or an HSA license in Singapore), file the request at least two weeks in advance, because the response time alone eats up one to two weeks across all four systems. Fourth, print every approved document: an email on a phone screen with no signal at the immigration counter doesn't replace paper. Fifth and last, organize the carry-on: medication in its original packaging with the label visible, prescription and medical letter physically on top, authorization document (when required) alongside, and never mixed in with the rest of the toiletry bag inside checked luggage. Anyone who follows this order arrives at the immigration counter with an answer ready for any question, which usually wraps up the check in minutes instead of hours. It's also worth keeping a digital copy of every document, in an email accessible offline or in the cloud, as a backup in case the paper gets lost or wet during the trip, though this never replaces the printed original at the point of inspection. And if the itinerary includes more than one country from this report, the same medication may require duplicate procedures: an approval for Japan doesn't work for the UAE or Korea, because each system is independent and evaluates the request without considering approval obtained in another country.